SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's Laboratories submits press release

14 Jun 2019 Evaluate

Dr. Reddy's Laboratories has informed about submission of a Press Release on ‘Dr. Reddy's Laboratories announces entering into a definitive agreement to sell its neurology branded products to Upsher-Smith Laboratories, LLC’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Labs. Share Price

1147.05 -3.85 (-0.33%)
28-Jul-2026 09:07 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1987.70
Dr. Reddys Labs. 1147.05
Cipla 1425.10
Lupin 2423.90
Zydus Lifesciences 1106.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: